Con: the use of modified ultrafiltration during pediatric cardiovascular surgery is not a benefit.
Ramamoorthy
C
C
Department of Anesthesiology, University of Washington School of Medicine, Seattle 98105, USA.
Lynn
A M
AM
D001834:Body Water / Q000378:metabolism; D001921:Brain / Q000378:metabolism; D002315:Cardiopulmonary Bypass / Q000009:adverse effects / Q000379:methods; D002630:Chemotactic Factors / Q000097:blood; D002648:Child; D016207:Cytokines / Q000097:blood; D006438:Hemodilution / Q000379:methods*; D006801:Humans; D018836:Inflammation Mediators / Q000097:blood; D009206:Myocardium / Q000378:metabolism; D015427:Reperfusion Injury / Q000097:blood / Q000209:etiology; D018746:Systemic Inflammatory Response Syndrome / Q000097:blood / Q000209:etiology; D016896:Treatment Outcome
D002630:Chemotactic Factors; D016207:Cytokines; D018836:Inflammation Mediators